CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives. SAN ANTONIO, TX / ACCESS ...
News
- CellRight Technologies, LLC Announces Update and Senior Leadership Changes
- BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
... San Antonio Breast Cancer Symposium taking place December 9-12, 2025 at ... When it comes to biotech ETFs, they give sector participants exposure to ...
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...
Ralph DeFronzo, Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio. ... biotech and finance leaders seeking clear, ...
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...
... San Antonio. The interview highlights the growing body of preclinical ... astr<60 is a webinar series created by astr partners for biotech and finance ...
- 1 in 4 ABC patients treated with Novartis Kisqali remain progression-free beyond 4 years
A fully integrated, R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.HK). ... biotech entity) and Shaoxing ...